American Society for Reproductive Medicine

08/18/2022 | Press release | Distributed by Public on 08/19/2022 00:15

ASRM Research Institute Discovery & Innovation Grant Letter of Intent Opens August 22nd, 2022

ASRM Research Institute Discovery & Innovation Grant Opens August 22nd

Aug 18, 2022
Author: ASRM Research Institute
Origin: ASRM Research Institute Announcement

The ASRM Research Institute Discovery & Innovation Grant ($50,000 per year or greater) letter of intent opens August 22nd, 2022. Investigators with a doctorate degree (MD, MD/PhD, PhD, ScD or equivalent) who meet eligibility, with expertise in reproductive health and science, are encouraged to submit a letter of intent for consideration. We invite investigators to develop research proposals that align with the ASRM Research Institute funding priorities and address fundamental questions of major clinical significance to reproductive medicine. All letters of intent are due on October 7th, and must include the following information:
  • Primary investigator information (full name, degree(s), title, institution)
  • Title of project
  • Abstract
  • Aims and anticipated outcomes
  • Impact statement
  • Estimated award requested (no formal budget is required)
The letter of intent with all required information must be submitted, as ONE PDF, to the ASRM Research Institute ([email protected]) no later than Friday, October 7th, 2022 to be considered.

Please Note: submission of a letter of intent does not ensure a full proposal invitation.
  • Information submitted will be evaluated by the ASRM Research Institute Advisory Committee.
  • Invitations to submit a full proposal will be sent on Friday, November 10th.
  • If your study/project is accepted you will need to submit a full proposal to ASRM by 4pm EST on February 15th, 2023.
To view eligibility criteria, funding priority areas, and grant timelines and guidelines please visit our website.

ASRM Announcements contain information of interest to members about ASRM and its affiliates, NIH, FDA, WHO, or CDC matters.